Neil Walker Gibson
- Catrx, Inc. (no department on record)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 79113691Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2026 onlyCareer claims are limited to the years shown.
NIH Funding · FY2026
Award data coverage
ScienceDex currently has one fiscal year of PI ranking data for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2026): $400K in linked award amounts across 1 award record · Award-linked rank #37304.
FY2026 award records by amount
NIH award records listing Neil Walker Gibson as a PI. Multi-PI records show the full award amount for context.
- 1R44CA306698-01A1R44Contact PIJAML is a first-in-class cancer immunotherapy target for tissue-resident memory T cells.$400Kaward amount
Award organization
Organizations that administered FY2026 awards listing Neil Walker Gibson as a PI.
FY2026 award administered by Catrx, Inc. (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2026First NIH AwardCatrx, Inc.
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Neil Walker Gibson.